Wednesday, July 8, 2026

pharma · Acute Cannabinoid Intoxication · ANEB

Anebulo Pharmaceuticals

Anebulo Pharmaceuticals clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Austin, USA HQ
10 Employees
Public company Type
ANEB · NYSE Ticker
Company details
Status
Public
HQ
Austin, USA
Employees
10
Programs
2
Drugs
0
Patents
1
Intelligence · Clinical Programs

Anebulo Pharmaceuticals projects

1 ClinicalTrials.gov programs sponsored by Anebulo Pharmaceuticals.

Anebulo Pharmaceuticals has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ANEB-001

    Anebulo Pharmaceuticals

    Acute Cannabinoid Intoxication

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Anebulo Pharmaceuticals have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.